CrowdfundedWealth

KBS REIT III Q3 2026 10-Q: Equity at $40.7M, Going Concern Stays

ResearchBy Jorge22 min read7 SEC filings cited

Some links pay us a referral fee; each one says so. Disclosure

Vehicle file: KBS Real Estate Investment Trust III, Inc. — assets, distributions, repurchases and every filing, as filed with the SEC.Open the file →

Filing alert · free

An email when KBS REIT III files with the SEC

An email the day KBS REIT III files something new, with the link to the document on the SEC site.

Quick answer

KBS Real Estate Investment Trust III, Inc. (SEC CIK 1482430) filed its 10-Q for the quarter ended September 30, 2026 on November 12, 2026 (accession 0001482430-26-000048). Its going-concern warning stands: management’s plans “may not be considered probable and thus do not alleviate substantial doubt about the Company’s ability to continue as a going concern.” The latest estimated value per share is $2.70, approved on December 18, 2025 (8-K, accession 0001482430-25-000057) on values as of September 30, 2025; the 10-Q reports no newer value. What changed in the third quarter is the balance sheet: total stockholders’ equity fell from $126.3 million at June 30, 2026 to $40.7 million at September 30, 2026 after an $85.6 million quarterly net loss, $51.6 million of it property impairments. Notes payable were $1,160.5 million, with $833.0 million in the schedule for October 1 to December 31, 2026. The company sold two office properties in 2026 ($50.0 million in March, $90.5 million in September), sold a third, The Almaden, for $82.0 million on October 8, 2026, has declared no distribution since June 2023 and redeemed no shares in 2026.

Key takeaways

  • Value per share: $2.70, approved December 18, 2025, within a Kroll range of $2.30 to $3.13 and based on September 30, 2025 values. The 10-Q has no newer estimate, even though it books $80.0 million of impairments in the first nine months of 2026. The 8-K says the going-concern risks “are not priced into” that value.
  • Equity: total stockholders’ equity was $40.7 million at September 30, 2026, against $126.3 million at June 30, 2026 and $177.8 million at December 31, 2025. On 148,516,246 shares that is about $0.27 a share of accounting equity (our arithmetic), a book figure that is not comparable with the $2.70 estimate.
  • Third quarter: net loss of $85.6 million against $4.2 million a year earlier, with $51.6 million of impairments on four office properties, a $10.7 million unrealized loss on the Prime US REIT units and a $4.7 million loss on the September sale.
  • Debt: $1,160.5 million of principal at September 30, 2026, down from $1,246.4 million at June 30, 2026. The 10-Q schedule puts $833.0 million in October to December 2026 and $327.5 million in 2027; debt was $1.0 billion on November 12, 2026 with a weighted-average remaining term of 0.2 years, and all of it matures or must be paid down within 12 months.
  • Sales: Gateway Tech Center for $50.0 million (March 2026), 515 Congress for $90.5 million (September 2026) and The Almaden for $82.0 million (October 8, 2026), a total of $222.5 million (our arithmetic). The Almaden’s $116.0 million loan was paid off at a discount from $76.3 million of net proceeds plus cash held.
  • A dated test inside the loans: the Amended and Restated Portfolio Loan Facility allows no more than four “Counted Projects” at December 31, 2026 and a facility of no more than $300.0 million, against five Counted Projects and $387.7 million of principal at September 30, 2026 (our count and arithmetic).
  • Holders: no distribution has been declared since June 2023, no shares were redeemed in the nine months, and the company says it does not expect to redeem any “until certain loans are repaid or refinanced.” The annual meeting is December 17, 2026.

CSV · 103 rows

KBS REIT III: value per share, balance sheet, results, sales, loans, going-concern items and dates from the Q3 2026 10-Q

Sourced rows from the September 30, 2026 10-Q, the June 30, 2026 10-Q, the December 2025 value 8-K and the autumn 2026 filings. SEC accession on every row.

The value on your statement, and the warning next to it

The number holders see is the board’s estimated value per share. On December 18, 2025 the board approved $2.70, based on net asset value as of September 30, 2025 with one adjustment for the Prime US REIT units as of November 14, 2025. Kroll’s range was $2.30 to $3.13, and the board used the approximate mid-range value. The 8-K says the value exists to help broker-dealers meet FINRA Rule 2231 account-statement duties, and that it would first appear on December 31, 2025 statements mailed in January 2026. It was $3.89 on December 12, 2024.

Component of the $2.70December 18, 2025 (per share)December 12, 2024 (per share)
Real estate properties$10.98$14.51
Investment in Prime US REIT units$0.26$0.19
Cash, restricted cash and cash equivalents$0.54$0.31
Other assets$0.07$0.15
Notes payable($8.63)($10.69)
Other liabilities($0.52)($0.58)
Estimated value per share$2.70$3.89

Two sentences from that 8-K matter more now than they did in December. The first: “These risks are not priced into the December 18, 2025 estimated value per share.” The risks are the going-concern and market risks described just before it. The second is the sensitivity: “a 1% decrease in the appraised value of the Appraised Properties would result in a decrease of $0.11 to the Company’s estimated value per share.”

Is $2.70 still the latest? Yes. The 10-Q, the 8-Ks of October 1 and November 5, 2026, and the proxy do not report a new estimated value, and the 10-Q text does not use the phrase. What the 10-Q does show is what has happened to the assets since September 30, 2025. In the nine months to September 30, 2026 the company recorded $79.971 million of impairments, $10.6 million in the first quarter, $17.8 million in the second and $51.6 million in the third, about $0.54 a share (our arithmetic). An impairment writes a carrying value down to estimated fair value and is not a restatement of the appraisal; it does not mean the next estimate will be any particular number.

For scale only: $2.70 times 148,516,246 shares is about $401.0 million (our arithmetic). Accounting equity at September 30, 2026 was $40.7 million, about $0.27 a share (our arithmetic). The two are built on different bases. The estimate rests on appraisals of properties and fair values of the notes, while accounting equity is cost less depreciation and impairments, and it has been falling by the quarter’s losses.

The going-concern warning, word for word

The warning sits in Note 2 of the 10-Q and again in Note 8 and in the discussion of liquidity. Its structure is the same as in the June 10-Q our review of KBS REIT III read, with new amounts.

  • What triggers it: “Through the normal course of operations,” the company has $1.0 billion of notes payable maturities and required principal paydowns in the 12 months after the financial statements were issued. Note 8 says this “raises substantial doubt as to the Company’s ability to continue as a going concern for at least a year from the date of the issuance of these financial statements.”
  • Why the plans do not clear it: management’s plans “may not be considered probable and thus do not alleviate substantial doubt about the Company’s ability to continue as a going concern,” because certain elements are “outside the control of the Company,” including repaying debt at maturity, making required paydowns, satisfying loan terms and selling assets.
  • What it says about sales: “Selling real estate assets in the current market may result in a lower sale price than the Company would otherwise obtain.”
  • What it says about the properties: “Additionally, the Company may relinquish ownership of one or more secured properties to the mortgage lender.”
  • What it says about bankruptcy (liquidity discussion): “We may also seek the protection of the bankruptcy court to implement a restructuring plan, which would constitute an event of default under our indebtedness.”

On the same date the loans carry cross-default provisions, and the 10-Q says the company had pledged the equity of the subsidiaries that own 201 17th Street, Carillon and Accenture Tower. It believed it was in compliance with its financial debt covenants at September 30, 2026. REIT Properties III, an indirect subsidiary, gives principal guarantees of $79.4 million (Accenture Tower, 25%), $38.8 million (portfolio facility, 10%) and $18.9 million (revolving facility, 25% of the commitment), $137.1 million together (our arithmetic).

What changed between June 30 and September 30, 2026

ItemJune 30, 2026September 30, 2026Change
Total assets$1,478.6 million$1,310.8 million-$167.8 million (our arithmetic)
Total liabilities$1,352.3 million$1,270.1 million-$82.2 million (our arithmetic)
Total stockholders’ equity$126.3 million$40.7 million-$85.6 million, the quarter’s net loss
Notes payable principal$1,246.4 million$1,160.5 million-$85.9 million (our arithmetic)
Real estate held for investment, net$1,229.0 million$1,079.8 million-$149.3 million (our arithmetic)
Prime US REIT units (book value)$38.2 million$27.5 million-$10.7 million
Cash and cash equivalents$26.6 million$27.9 million+$1.3 million (our arithmetic)
Restricted cash$39.6 million$31.1 million-$8.5 million (our arithmetic)
Office properties held for investment11 (about 5.4 million sq ft)10 (about 5.2 million sq ft)One sold in September
Portfolio occupancy77.0%75.9%-1.1 points (our arithmetic)
Accenture Tower occupancy88.5%88.8%+0.3 points (our arithmetic)

The equity line is the quarter in one number. Equity at June 30, 2026 was $126.3 million; the quarter’s net loss was $85.6 million; there were no distributions, redemptions or share sales to offset it, so equity at September 30, 2026 is $40.7 million. In the nine months it fell from $177.8 million to $40.7 million (net loss $137.1 million).

Income statement lineThree months to September 30, 2026Three months to September 30, 2025Nine months 2026
Total revenues$55.7 million$61.6 million$170.0 million
Interest expense$24.4 million$29.1 million$73.8 million
Impairment charges on real estate$51.6 million$65.5 million$80.0 million
Unrealized (loss) gain on Prime US REIT units($10.7 million)$8.5 million($19.2 million)
(Loss) gain on sale of real estate($4.7 million)$77.4 million$18.1 million
Net loss($85.6 million)($4.2 million)($137.1 million)
Net loss per share($0.58)($0.03)($0.92)

The third-quarter impairment of $51.6 million covers four office properties. The 10-Q says one was written down on “offers received” while it was marketed for sale, and the other three on higher terminal capitalization and discount rates, lower projected revenue, higher vacancy and slower rent growth in their central business districts. It does not name them. For the nine months, net cash from operations was $15.7 million, interest paid was $56.2 million and improvements to real estate cost $20.0 million (nine months 2025: $3.5 million, $70.9 million and $18.5 million).

What was sold, and for how much

PropertyWhenPriceResult and use of proceeds
Office property sold in July 2025July 2025$126.5 million$87.7 million of net proceeds repaid the Amended and Restated Portfolio Loan Facility
Park Place Village (mixed-use)September 2025$100.0 millionGain on the two 2025 sales: $77.4 million; Credit Facility paid down by $25.4 million
Gateway Tech CenterMarch 2026$50.0 millionGain $22.8 million; $47.5 million of $48.1 million net proceeds repaid the revolving facility
515 Congress (Austin)September 2026$90.5 millionLoss $4.7 million; $83.2 million of net proceeds paid down the revolving facility, plus $1.8 million from the tax escrow
The Almaden (San Jose)October 8, 2026$82.0 million gross, $76.3 million netLoan of $116.0 million paid off “at a discount” by paying net sales proceeds plus cash and deposits held

Two things the table shows. First, 2026 sales so far total $222.5 million at contract price (our arithmetic), and nearly all of the cash has gone to lenders: $47.5 million and $84.9 million repaid on the revolving facility in March and September 2026. The 10-Q reports $135.5 million of net sale proceeds in the nine months and $136.7 million of principal repaid. Second, The Almaden’s loan was larger than the building’s sale: its $116.0 million book balance against $76.3 million of net proceeds leaves up to about $39.7 million that the lender accepted as a discount (our arithmetic; the exact payoff includes cash and deposits held and is not stated). The Almaden had been carried at $71.7 million net at September 30, 2026, so the price beat the carrying value but not the loan.

Rental income is falling with the sales: $50.5 million in the quarter against $57.1 million a year earlier, and the company expects it “to decrease in future periods” after the September and October 2026 sales. The 10-Q records accrued disposition fees to the Advisor of $0.9 million for Gateway Tech Center and 515 Congress, to be paid only after the senior debt is paid in full under the revolving facility terms; The Almaden carries another $0.5 million.

Loans: what matured, what moved, what is left

LoanPrincipal at June 30, 2026Principal at September 30, 2026Maturity (10-Q table)After the October 30, 2026 8-K
The Almaden Mortgage Loan$116.1 million$116.0 millionNovember 1, 2026Paid off October 8, 2026 at a discount
Carillon Mortgage Loan$89.5 million$89.1 millionDecember 31, 2026No change in the filings we read
Modified Portfolio Revolving Loan Facility$160.4 million$75.5 millionDecember 15, 2026Extension to March 31, 2027 only if conditions are met
3001 & 3003 Washington Mortgage Loan$137.8 million$137.8 millionNovember 2, 2026January 20, 2027, no further options
Accenture Tower Loan$317.4 million$317.4 millionNovember 2, 2026December 17, 2026, option to November 2, 2027
Credit Facility$37.5 million$37.0 millionSeptember 30, 2027Property-sale milestone moved to January 20, 2027
Amended and Restated Portfolio Loan Facility$387.7 million$387.7 millionJanuary 22, 2027Two 12-month options; $300.0 million cap by December 31, 2026
Total principal$1,246.4 million$1,160.5 million$1.0 billion at November 12, 2026, 0.2 years average term

Details of the first two extensions are in our 8-K reading of the Accenture Tower and Washington loans. This 10-Q adds what that page could not yet say.

The scheduled 2026 amount fell by exactly the principal repaid. At June 30, 2026 the 10-Q scheduled $918.9 million for July 1 to December 31, 2026 and $327.5 million for 2027. At September 30, 2026 it scheduled $833.0 million for October 1 to December 31, 2026 and the same $327.5 million for 2027. The $833.0 million is 71.8% of principal, and the drop from $918.9 million is $85.9 million, the same as the fall in principal (our arithmetic). The schedule is drawn at September 30, 2026 and still includes loans the November 5 8-K moved: the Washington loan ($137.8 million) now falls in January 2027, so by the filings the amount actually due in 2026 is lower than the 10-Q table shows, and the January 2027 amount higher.

Our arithmetic on what the $833.0 million is made of, from the loan table and the covenants (the 10-Q gives the total, not the split): loans maturing in the quarter, $735.8 million (Almaden, Carillon, revolving, Washington, Accenture); the cut of the Amended and Restated Portfolio Loan Facility from $387.7 million to $300.0 million by December 31, 2026, $87.7 million; and a $9.5 million Credit Facility paydown. The three add to $833.0 million. Five loans (Carillon, revolving, Washington, Accenture and the portfolio facility) total $1,007.6 million and mature between December 15, 2026 and January 22, 2027 (our arithmetic), 86.8% of principal.

Two covenants turn into dated tests:

  • Portfolio facility, by December 31, 2026: the maximum facility amount may not exceed $300.0 million, and the company may not own more than four Counted Projects. The Counted Projects are 60 South Sixth, Towers at Emeryville, Ten Almaden, Town Center and Accenture Tower, which is five today (our count from the 10-Q definition). On our reading, one of them has to be sold, or the terms changed, by that date.
  • Credit Facility, by January 20, 2027: a property sale, with 50% of the net proceeds paying down at least $9.5 million to no more than $27.5 million. On September 30, 2026 the company paid $0.5 million, taking the balance to $37.0 million, and the sale milestone that had been due that day moved to January 20, 2027.

All the loans bear variable rates, and “all of our interest rate swaps had expired” as of November 1, 2026, so, as the 10-Q puts it, “our interest expense will increase.”

Distributions, redemptions and the Prime US REIT units

  • Distributions: “We have not declared any distributions since June 2023.” The company says “we do not expect to pay any dividends or distributions until certain loans are repaid or refinanced,” and that if it pays any it will “likely fund distributions from the sale of assets.”
  • Redemptions: none in the nine months to September 30, 2026. The share redemption program and the distribution reinvestment plan were terminated on March 15, 2024, and the 10-Q says “we do not expect to redeem any shares of common stock until certain loans are repaid or refinanced.” Since the offering, the company has redeemed or repurchased 74,644,349 shares for $789.2 million.
  • Prime US REIT units: 237,426,088 units, 16.5% of that Singapore REIT, bought at $0.88 a unit in July 2019 for $271.0 million. At September 30, 2026 they were carried at $27.5 million ($0.116 a unit) and at November 12, 2026 they were worth $26.6 million ($0.112 a unit) on the exchange price, before any discount for the size of the holding. The proceeds are pledged to the portfolio lenders through a cash collateral account.
  • The Advisor: the advisory agreement was renewed on September 27, 2026 through September 27, 2027 (8-K filed October 1, 2026), terminable on 60 days’ written notice without cause or penalty. Asset management fees were $4.2 million in the quarter and $12.4 million in nine months. $8.5 million of fees deferred before October 2022 remains unpaid.

What the 10-Q does not say

  • No new estimated value per share. It does not say when the next one will be set. The two most recent were approved on December 12, 2024 and December 18, 2025; we do not predict a date.
  • No property names for the third-quarter impairments, and no appraised or offered values to compare with the $10.98 a share of real estate in the December 2025 value.
  • No amount for the Almaden payoff. It states the formula, net sales proceeds plus cash and deposits held, not the figure.
  • The conditions for the extension options. The Accenture Tower and revolving facility options depend on conditions the filings describe only as “subject to the satisfaction of certain terms and conditions.” The revolving facility’s include some that are “not in the sole control of the Company.”
  • No forecast of liquidity after the December dates. The company says only that “there can be no assurances as to the certainty or timing of management’s future plans.”
  • Liquidation: on September 30, 2026 the conflicts committee “unanimously determined to postpone approval of our liquidation” and must revisit the question at least annually.

Dates to watch

DateWhat happensSource
December 15, 2026Modified Portfolio Revolving Loan Facility matures ($75.5 million at September 30, 2026); extension to March 31, 2027 needs conditions to be met10-Q, Note 8
December 16, 2026Proxy voting closes at 11:59 PM ETDEFA14A, September 22, 2026
December 17, 2026Accenture Tower Loan matures ($317.4 million); annual meeting of stockholders, 9:00 a.m. Pacific, Newport Beach; five directors and Ernst & Young on the ballot, record date September 21, 20268-K November 5, 2026; DEF 14A
December 31, 2026Carillon loan matures ($89.1 million); portfolio facility to no more than $300.0 million and four Counted Projects10-Q, Note 8
January 20, 20273001 & 3003 Washington loan matures ($137.8 million), no further options; Credit Facility property-sale milestone8-K November 5, 2026; 10-Q
January 22, 2027Amended and Restated Portfolio Loan Facility matures ($387.7 million), with two 12-month options10-Q, Note 8

Under the proxy, a director nominee needs a majority of the shares entitled to vote, abstentions and broker non-votes “will have the effect of a vote against each nominee for director,” and a nominee who falls short stays on as a “holdover” director. Our calendar of non-traded REIT meetings tracks this one, and our history of the KBS REITs shows how the earlier ones ended.

What a reader can do with this

This is analysis of public documents, not investment, legal or tax advice.

  1. Check which number your statement shows. If it says $2.70, that is the December 18, 2025 estimate, set on September 30, 2025 values. Since then the company has booked $80.0 million of impairments and sold three properties. Nothing in the 10-Q says what the next estimate will be.
  2. Put the debt dates next to the vote. December 15, 17 and 31, 2026 and January 20 and 22, 2027 are the dates by which the 10-Q’s own schedule will be tested. If you hold directly, the annual meeting on December 17, 2026 is the one place holders have a say.
  3. Read the sale conditions, not only the sale prices. The sales so far went to lenders. The portfolio facility needs one more of five properties sold, or its terms changed, by December 31, 2026.
  4. Ask a tax professional how a loss on shares that cannot be redeemed is treated, especially inside an IRA, where the estimated value is the number custodians use.

FAQ

Frequently Asked Questions

Sources: KBS Real Estate Investment Trust III, Inc. Form 10-Q for the quarter ended September 30, 2026, filed November 12, 2026 (accession 0001482430-26-000048); Form 10-Q for the quarter ended June 30, 2026 (0001482430-26-000026); Form 8-K filed December 19, 2025 on the estimated value per share (0001482430-25-000057); Form 8-K filed November 5, 2026 for the event of October 30, 2026 (0001482430-26-000044); Form 8-K filed October 1, 2026 (0001482430-26-000041); Form DEF 14A (0001482430-26-000037) and DEFA14A (0001482430-26-000038) filed September 22, 2026. Figures marked “our arithmetic” are ours. This is analysis of public documents, not investment, legal or tax advice.

Affiliate Disclosure: Some links are affiliate links. We may earn a commission at no extra cost to you. This does not affect our ratings. Learn more.